Apple is reportedly exploring a potential acquisition of artificial intelligence startup Perplexity, according to Bloomberg News. The internal discussions, which involve Apple’s M&A chief Adrian Perica, services head Eddy Cue, and key AI decision-makers, are still in early stages and no formal offer has been made. Perplexity has not been approached by Apple and stated it has “no knowledge of any current or future M&A discussions.”
The move would mark a significant shift for Apple as it seeks to enhance its AI capabilities. The company is reportedly interested in integrating AI-powered search tools—like those developed by Perplexity—into its Safari browser, potentially signaling a departure from its long-standing partnership with Google, which currently powers default search on Apple devices. This comes as the U.S. Department of Justice pushes antitrust remedies that could prevent Google from paying to maintain that default position.
Perplexity, backed by Nvidia and recently valued at $14 billion, is gaining traction with AI-driven search solutions that offer direct information summaries, challenging traditional search engines like Google. The startup competes with other generative AI tools such as OpenAI’s ChatGPT and Google’s Gemini and is particularly popular among younger users seeking faster, context-rich answers.
Meanwhile, Meta Platforms also showed acquisition interest in Perplexity earlier this year, according to Bloomberg. Meta has aggressively expanded its AI ambitions, investing $14.8 billion in Scale AI and appointing Scale’s CEO to lead its superintelligence division.
As tech giants race to lead in AI, Apple’s potential bid for Perplexity reflects the growing importance of next-gen search technologies in maintaining user engagement and market dominance. If pursued, it could be Apple’s largest acquisition to date.


Morgan Stanley Names Top AI Security and Data Center Stocks for 2026
Universal Music Group Rejects Pershing Square Takeover Proposal
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks
US Quantum Stocks Surge After $2 Billion Government Investment
Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand
CTOC Goes Live on Bitget Wallet Trading, Expanding Global Access to AI-Powered Healthcare Data Ecosystem
DOJ Investigates Group Linked to Reid Hoffman Over E. Jean Carroll Lawsuit Funding
Samsung to Invest $1.5 Billion in Vietnam Semiconductor Testing Plant by 2027
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
Samsung Workers Approve Wage Deal, Avoiding Major Strike and Boosting Chip Supply Confidence
Elon Musk Explores Possible Tesla-SpaceX Merger Amid Growing AI Investments
Synopsys Q2 FY2026 Earnings Beat Driven by AI and Semiconductor Demand
Snowflake Stock Soars 30% After Q1 Earnings Beat and Major AWS AI Partnership
Australia Sues 3M for Over A$2 Billion Over PFAS Firefighting Foam Contamination
Meta Subscription Push Could Add Billions in Recurring Revenue, Says Rosenblatt
Dell Raises 2027 Revenue Forecast as AI Server Demand Drives Record Quarterly Results
SpaceX IPO Hype Raises Questions as Many Major Stock Debuts Underperform Market 



